Xin-yu Shi
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The role of the pleural fluid lactate dehydrogenase/adenosine deaminase ratio in differentiating between tuberculosis pleural effusion and parapneumonic effusion: a retrospective cohort study and meta-analysis.
Journal: Journal of thoracic disease
Published: December 31, 2024
IFN-γ Induces Pleural Mesothelial Cells to Recruit Immune Cells via CXCL10-CXCR3 Axis in a Mouse Pleurisy Model.
Journal: Journal of inflammation research
Published: November 01, 2024
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study.
Journal: Thrombosis journal
Published: March 26, 2024
EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis.
Journal: Journal of thrombosis and thrombolysis
Published: October 13, 2023
S100A9 Regulated M1/M2 Macrophage Polarization in Interleukin-10-Induced Promotion of Malignant Pleural Effusion.
Journal: Journal of immunology research
Published: February 24, 2023
Total Protein-Chloride Ratio in Pleural Fluid Independently Predicts Overall Survival in Malignant Pleural Effusion at the First Diagnosis.
Journal: Frontiers in oncology
Published: September 16, 2021
TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 24, 2020
IL-10 promotes malignant pleural effusion by regulating TH 1 response via an miR-7116-5p/GPR55/ERK pathway in mice.
Journal: European journal of immunology
Published: January 30, 2020
Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Journal: Thoracic cancer
Published: September 27, 2019
The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.
Journal: Medicine
Published: August 09, 2019
Last Updated: 09/26/2026